Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2020 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2020 |
(iii) Distributable Amount for 2020 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2020 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2020: | ||||
| a From 2015....... | ||||
| b From 2016....... | ||||
| c From 2017....... | ||||
| d From 2018....... | ||||
| e From 2019....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2020 distributable amount | ||||
|
i
Carryover from 2015 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2020 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2020 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2020, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2020. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2021. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2016..... | ||||
| b Excess from 2017..... | ||||
| c Excess from 2018..... | ||||
| d Excess from 2019..... | ||||
| e Excess from 2020..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PART I, LINE 6 | FROM TEENAGERS TO GREAT GRANDPARENTS, FROM HOMEMAKERS TO PROFESSIONAL ATHLETES, CHILDREN'S HOSPITAL COLORADO VOLUNTEERS ENCOMPASS ALL WALKS OF LIFE AND ALL INCOME LEVELS, EACH VOLUNTEER WITH SOMETHING UNIQUE TO OFFER. OUR DIVERSE GROUP OF VOLUNTEERS HAS ONE THING IN COMMON, HOWEVER, THE DESIRE TO HELP SICK CHILDREN AND THEIR FAMILIES. CHILDREN'S HOSPITAL COLORADO IS FORTUNATE TO HAVE HUNDREDS OF DEDICATED VOLUNTEERS WHO WORK REGULARLY, FROM SEVERAL HOURS A YEAR TO SEVERAL HOURS A WEEK, TO PROVIDE BETTER CARE FOR THE CHILDREN OF CHILDREN'S HOSPITAL COLORADO. THE ASSOCIATION OF VOLUNTEERS THE VOLUNTEERS AT CHILDREN'S HOSPITAL COLORADO ARE ALL PART OF A GROUP CALLED CHILDREN'S HOSPITAL COLORADO ASSOCIATION OF VOLUNTEERS (AOV). THE AOV COORDINATES PLACEMENTS FOR VOLUNTEERS AND ENSURES THAT COMPLETE ORIENTATION AND TRAINING IS PROVIDED TO ALL VOLUNTEERS. OUR VOLUNTEER'S SKILLS AND INTERESTS ARE ALL SO APPRECIATED AND WE TRY TO PLACE EVERYONE IN A ROLE THAT SUITS THEM AND OUR NEEDS. THE EXAMPLES BELOW ARE JUST SOME OF THE WAYS THAT OUR VOLUNTEERS CONTRIBUTE: - VOLUNTEERS ARE ACTIVE AT THE HOSPITAL ON THE ANSCHUTZ MEDICAL CAMPUS, THE SOUTH CAMPUS, HIGHLANDS RANCH THERAPY CARE CENTER, BRIARGATE, COLORADO SPRINGS HOSPITAL AND THE NORTH CAMPUS. - VOLUNTEERS SPEND TIME WITH OUR PATIENTS BY HOLDING, COMFORTING, PLAYING WITH THEM AND MAKING THEM LAUGH. - VOLUNTEERS BRING SPECIALLY-SCREENED DOGS TO PROVIDE ANIMAL-ASSISTED THERAPY FOR THE PRESCRIPTION PET PROGRAM. - SPECIALLY TRAINED VOLUNTEERS SERVE AS AMBASSADORS WITH THE WELCOME PROGRAM. VOLUNTEERS GREET NEWLY ADMITTED PATIENT FAMILIES UPON THEIR ARRIVAL AND INTRODUCE THEM TO THE HOSPITAL'S MANY AMENITIES. THE GOAL IS TO PROVIDE A WARM AND WELCOMING ENVIRONMENT AND TO ANSWER ANY NON-MEDICAL QUESTIONS. - THE WINE EVENT IS THE ASSOCIATION OF VOLUNTEERS' SIGNATURE EVENT. THE SPECIAL EVENING FEATURES A SILENT AND LIVE AUCTION OF FINE WINES AND EXPERIENCES WITH ALL PROCEEDS BENEFITING THE MATERNAL FETAL MEDICINE PROGRAM. - MANY GROUPS OF VOLUNTEERS DO NOT SPEND TIME DIRECTLY WITH OUR PATIENTS, BUT PERFORM MORE ADMINISTRATIVE DUTIES, WHICH CAN BE JUST AS IMPORTANT TO THE DAY-TO-DAY OPERATIONS OF CHILDREN'S HOSPITAL COLORADO. - TEENAGERS BETWEEN 13 AND 18 YEARS OF AGE PARTICIPATE IN THE JUNIOR VOLUNTEER PROGRAM. THEY SUPPORT THE HOSPITAL BY WORKING IN SEVERAL DEPARTMENTS AS WELL AS SUPPORTING FUNDRAISING ACTIVITIES. - VOLUNTEERS ALSO ASSIST IN FUNDRAISING BY STAFFING CHILDREN'S HOSPITAL COLORADO GIFT SHOP AND LA CACHE. - CHAPTER VOLUNTEERS IN THE COMMUNITY ARE VERY ACTIVE IN FUNDRAISING EVENTS THROUGHOUT THE YEAR THAT HELP TO FUND SPECIAL EQUIPMENT, FACILITIES AND PROGRAMS FOR THE PATIENTS OF CHILDREN'S HOSPITAL COLORADO. |
| FORM 990, PART III, LINE 4A | Neonatology For more than 50 years, the Neonatal Intensive Care Unit (NICU) at Children's Hospital Colorado has been a nationally recognized leader in the treatment of critically ill infants. The state-of-the-art Level IV NICU (the highest distinction by the American Academy of Pediatrics), at Children's Hospital Colorado, provides 82 critical care beds specifically for this patient population. The NICU provides excellent care for infants throughout Colorado and the mountain state region. Named one of the country's top centers by U.S. News & World Report, our Level IV Neonatal Intensive Care Unit offers the highest level of care to more than 2,000 newborns every year - one of the largest centers in the region. We care for any condition affecting a newborn, no matter how rare or critical that condition may be. Therapies include extra corporeal membrane oxygenation (ECMO), genetic testing, and neonatal surgery. Volumes matter. Children's Colorado's NICU is among the highest volume centers in the U.S. for high-complexity patients, meaning we see more and treat more neonates with complex congenital conditions and severe complications of prematurity than most other centers. The NICU cares for both premature and term infants with a variety conditions, including hypoxic respiratory failure, infections, hematological, neurological, cardiovascular and metabolic disorders. Infants with single major or multiple anomalies requiring diagnostic evaluation or surgical intervention are often treated in the NICU. Our survival rates rank among the best in the nation. Our high volumes not only allow for the development of highly specialized teams and standardized approaches to care, they also build our surgical and medical sub-specialists' experience and expertise. The Neonatology team has pioneered many critical developments in neonatal care including surfactant replacement for premature infants, inhaled nitric oxide therapy for pulmonary hypotension, therapeutic hypothermia for perinatal brain injury, optimal nutrition for low-birth-weight infants and innovative care following fetal surgery. Collectively, the neonatologists and PhD research faculty published 90 articles in 2020. Throughout a visit, a baby and their family stay together in an environment we specifically designed to feel as much like home as possible. Families are integral to the care delivered and key areas of focus include developmentally supportive care of the newborn, primary nursing and a family centered care approach. They are encouraged to participate in daily rounds and in all aspects of care. There is a Family Advisory Council to support current families and provide perspective on the patient experience. The clinical care team in the NICU is comprised of Neonatologists, Neonatal Nurse Practitioners, specialty trained nurses, respiratory therapists, pharmacists, physical, speech and occupational therapists, lactation specialists, neonatal nutrition, social work, chaplains, and case managers. Specialty consultants include neurology, pulmonology, genetics, gastroenterology, nutrition, metabolic, endocrinology, hematology, cardiology and cardiovascular surgery, general pediatric surgery, renal, ophthalmology, orthopedics and ear, nose and throat specialists. Children's Hospital Colorado neonatologists have diverse expertise caring for an array of complex conditions. The Section of Neonatology provides full clinical support for infants and their families at multiple hospitals in the Denver metropolitan area including Children's Hospital Colorado, University of Colorado Hospital and Denver Health Medical Center. The 36 board-certified neonatologists are nationally and internationally recognized leaders in neonatal care as well as clinical and scientific research. With advances in technology, the NICU team can provide teleconferencing for referring providers and/or parents who may not be present to provide optimal communication. They can also provide tele-NICU services to hospitals in rural areas to ensure those infants are properly treated in their home community and transferred only when appropriate. The NICU team continuously reviews quality and patient safety data focusing on excellence in patient outcomes. The NICU leadership team meets bimonthly for Quality Rounds, promoting engagement of front-line staff. This avenue elicits great discussions among staff regarding what is going well as well as in identifying opportunities and creative ideas for improvement. The NICU team promotes the safest environment possible with key communication in safety huddles each shift to review details of our safety and quality improvement work. Optimal communication with a large multidisciplinary team is one of our key strategies to promote the highest quality care possible. 2021 NICU Quality and Process Improvement Initiatives: . Increasing the family experience scores to 80% or greater. The NICU is involved in a regional collaborative to improve family engagement and satisfaction within NICU's, focusing on parents as partners in care and consistent, frequent communication. Strong foundation of Primary nursing for patients and families remains a model of care within the NICU. . The NICU continues work with a large national quality improvement initiative, Children's Hospital Neonatal Consortium (CHNC) focusing on the standardization of unique clinical quality measures of the surgical and critically ill neonate. . Ongoing key quality initiatives include focusing on decreasing unplanned extubations, patient identification events, pressure injuries, adverse medication events and peripheral intravenous catheter extravasations. . There is major focus on infection prevention practices and hand washing compliance among the large multidisciplinary team in the NICU. . Continue a significant focus on the prevention of central line associated blood stream infections (CLABSI). Our goal is to sustain a CLABSI goal of 2/1000-line days or less in 2021. Following staff compliance to the CLABSI bundle of prevention measures and auditing clinical practices related to CLABSI prevention. . Lactation program focuses on a goal of 82% or greater of NICU infants receiving breast milk while hospitalized and upon discharge. In addition, there are several other quality projects with a nutrition focus lead by Clinician Nutrition and the broader multi-disciplinary team. . Following clinical outcomes of infants delivered in the Labor and Delivery Care Unit at CHCO and admitted to the NICU at CHCO. . Trending data from codes/resuscitations in the NICU with processes identified for improvement, including code simulations and standardization of processes within the resuscitation. . A standardized, evidenced based approach to caring for infants in the Small Baby Unit within the NICU. Key clinical outcomes are tracked and reviewed in this patient population. . Close follow up of infants treated with hypothermic therapy for neonatal encephalopathy, unique ventilation strategies, Supporting Preemie Respiratory Outcomes (SPROUT) Transitional Team, extracorporeal membrane oxygenation (ECMO), inhaled nitric oxide (iNO), continuous renal replacement therapy (CRRT) and renal dialysis. |
| FORM 990, PART III, LINE 4A (cont'd) | CENTER FOR CANCER AND BLOOD DISORDERS Children's Hospital Colorado's Center for Cancer and Blood Disorders (CCBD) has one of the best pediatric hematology, oncology, and bone marrow transplant programs in the country. The CCBD has been ranked in the Top 10 programs by US News & World Report. The Center provides care for many pediatric cancers & blood disorders including: Oncology, Solid Tumors, Neuro- Oncology, Hemophilia & Thrombosis, Hematology, Experimental Therapeutics, and Bone Marrow Transplant & Cell Therapy. Helping children realize their full potential is also achieved through our Wellness Program, Adolescent & Young Adult care, and our HOPE survivorship program. Every year we see more between 300-350 new cancer diagnoses. The CCBD experienced 24,872 patient visits in 2020, seeking to serve the Colorado community, as well as our 7-state region. Of these visits 91% of patients were from Colorado while the remaining almost 9% were from the 7-state region or beyond. Our Anschutz facility location saw 17,582 visits of the total visits, with our infusion center volume making up 30% of those visits. Our Network of Care sites in Highlands Ranch, Colorado Springs, and our Hemophilia Thrombosis Center had patient visits in 2020 of 7,870 of which 33% were infusions. In early 2020, we expanded care to include infusion services at North Campus in Broomfield, Colorado. Because of the depth and breadth of CCBD outpatient services, a large number of our clinic and infusion visits mean that many children can be cared for on an outpatient basis instead of being admitted to the hospital. Limiting hospitalization when possible is our high priority to enable our families live healthier lives. CCBD Inpatient had 8,661 patient days recorded in 2020; 1.3% of these occurred at Children's Hospital Colorado, Colorado Springs. The Anschutz Medical Campus inpatient unit had a total of 6,691 inpatient Hematology and Oncology patient days and 1,970 BMT patient days recorded. National/Regional Presence: CCBD has an outreach program reaching from Montana to New Mexico with extensive presence in Colorado. Our outreach clinics in Grand Junction bring Hematology sub-specialty expertise to the Western slope. Our Hemophilia & Thrombosis Center (HTC) provides comprehensive care clinics throughout the region. We host bi-weekly Bone Marrow Transplant (BMT) teleconferences with cancer programs in New Mexico. Our CCBD nursing program travels throughout the region and provides virtual teaching to train other hospital nurse staff on best practices in chemotherapy administration. In 2020 we expanded our telemedicine efforts. We were successful in arranging physician licensing, credentialing, and contracts in Montana and New Mexico. Our HTC faculty successfully treated rural out of state patients via telemedicine in 2020, and they have set the stage for expanding this platform. CCBD is acknowledged by Optum as a Center of Excellence for both our Cancer Care as well as Bone Marrow Transplant. We are the only pediatric Foundation for the Accreditation of Cellular Therapy (FACT) program in a 16-state region, which brings us the capacity to deliver the most sophisticated stem cell transplant and chimeric antigen receptor T (CAR- T) cell immunotherapy. Continued expansion of the application of CAR-T therapy has also advanced in both the targeted antibodies and different diseases. Our Neuro-Oncology and Experimental Therapeutics programs draw patients nationally and internationally for treatment and clinical trials that are available in only a few centers in the world. CCBD Fellowship Program: Each year we select 4 new fellows to join our highly selective 3-year Accreditation Council of Graduate Medical Education-sanctioned Fellowship Program. Our fellows train in all aspects of sub-specialty care of children, adolescents and young adults with blood and cancer disorders in preparation for a career in academic medicine. We emphasize excellence in clinical care and research, developing fellows in the physician-scientist model with numerous mentors among the faculty such that our graduates acquire the skills and strategies needed for a career as life-long learners, educators, and influential leaders. We have successfully prepared subspecialty pediatricians that provide comprehensive, patient- and family-centered care with particular focus on excellent communication skills, as well as safety and quality improvement. Training the next generation of physicians is imperative to the health of children in our communities. Multi & Interdisciplinary Care: CCBD is privileged to have a dedicated Wellness program. This interdisciplinary team is comprised of specialists in Social Work, Psychology, Child Life, Family Navigation, Creative Arts Therapy, Chaplaincy, and Learning Specialists. The Wellness program benefits families and patients by integrating and coordinating clinical services to meet every family's needs at the individual level and increases possibilities for prevention/intervention and on-going care and connection. The CCBD is a home for multiple sub-programs within Oncology, Hematology and BMT. Our Vascular Anomalies Center is also a national and regional leader. This interdisciplinary team evaluates and treats vascular anomalies in children. NThe team includes specialists from Otolaryngology (ear, nose, and throat), Plastic Surgery, Dermatology, Hematology, Pediatric General Surgery, and Interventional Radiology. This program exemplifies our priority to put the patient first. Our specialists coordinate their care in one patient appointment to minimize the number of visits needed to evaluate and treat the patient's condition. Quality Improvement: The CCBD is committed to developing quality improvement as a core clinical strategy by continually advancing the effectiveness, efficiency, safety, experience, and coordination of the care it provides to its patients. The Clinical Effectiveness Collaborative (CEC) supports data driven improvement work on clinical effectiveness, operational excellence, and value throughout the CCBD, CHC, and the University of Colorado Anschutz Medical Campus with multidisciplinary standing membership drawn from individuals within the CCBD who can provide meaningful review and guidance to projects shared and supported by the CEC. The CEC is broadly representative, multidisciplinary and guides the range of activities and initiatives through which the CCBD is pursuing its clinical, operational, value-driven, and financial improvement goals. One primary function of the CEC is to review and provide feedback related to clinical and operational improvement projects, including measures, PI methods, and project alignment across the CCBD and CHC. The Collaborative's members help guide clinical and operational improvement initiatives, spread successful interventions, identify, and recommend strategies to overcome barriers/challenges, and serve as enthusiastic advocates for, participants and leaders of continuous learning and improvement in their respective areas and across the CCBD. The CCBD has several active Quality & Process Improvement initiatives underway in 2020 (and continuing into 2021) to include, but not limited to: . The CCBD areas of patient care patient satisfaction meet or exceed all other patient care areas within Children's Hospital Colorado. . Standardizing an approach to screening for transfusion-associated iron overload increasing the number of patients identified and treated for this complication and preventing long-term toxicities. . Decreasing length of stay of high-dose methotrexate admissions resulting in more time outside the hospital for children with leukemia and osteosarcoma. . Preventing blood stream infections in patients with a central line/catheter. . Improving time to antibiotics for patients receiving cancer care that present with fever and neutropenia (low white blood cell count) in all settings: Emergency Department & Outpatient clinic. . Decreasing the rate of clostridium difficile infections resulting in decreased mortality, decreased length of inpatient hospital stay and decreased cost for both community and hospital onset. . Increase reliability rates of Chemotherapy administered: both prescribing and administration process. . Successful Foundation for the Accreditation of Cellular Therapy (FACT) re-accreditation. FACT accreditation is a threshold for excellence in cellular therapy within the bone marrow or cord blood transplant (BMT) patient population. . Evaluating and changing the Bone Marrow Harvest process to reduce the positive sterility rate of products collected by CHCO providers. |
| FORM 990, PART III, LINE 4A (cont'd) | Neurosciences Children's Hospital Colorado's Neuroscience Institute (NSI) has one of the best developmental pediatrics, neurology, and neurosurgery programs in the country. We have consistently ranked among the Top 15 programs by U.S. News & World Report and ranked #10 in 2020-21 and 2021-22. The NSI provides evaluation and treatment of neurological disorders, parent and patient education, and inpatient and outpatient treatments, therapies and procedures. Our neurology team is specially trained to diagnose and treat disorders of the brain and nervous system, caring for kids with conditions like stroke, neuromuscular disorders, movement disorders, neurometabolic disorders, epilepsy, and migraines. Our neurosurgery team provides surgical treatment for all types of disorders affecting the brain, spinal cord and skull including epilepsy, hydrocephalus, traumatic injury, brain tumors, spina bifida, and facial and skull deformities. Our Developmental Pediatrics team sees children with a variety of developmental and neurobehavioral differences such as autism spectrum disorders, X&Y chromosome variations, fragile X and developmental delays. NSI includes more than 50 physicians, 26 advanced practice providers, and 29 psychologists across 8 Children's sites as well as 7 outreach sites across Colorado and a growing telemedicine practice. The clinical care team is comprised of neurologists, neurosurgeons, developmental pediatricians, neuropsychologists, psychologists, advanced practice providers, as well as specially trained nurses, genetic counselors, social workers, nutritionists, pharmacists, and physical, speech and occupational therapists. Our Children's sites include Anschutz, COS/Briargate, North/Broomfield, Parker, Uptown, Wheatridge, South, Highlands Ranch Therapy. The NSI saw 32,742 patient visits in 2020, serving the Colorado community and our 7-state region. With the pandemic, NSI was quick to shift to telemedicine, quickly training our providers, and implementing new workflows with clinical and administrative support staff. As a result, NSI had 13,926 telemedicine visits in 2020, which enabled us to continue to provide much needed care. Our providers were at the forefront of researching the impact of telemedicine visits in pediatric neurology and contributing to national guidelines for the neuro exam in a telemedicine visit. Due to the consistent demand for NSI's services, we continue to expand our outreach and telemedicine efforts to better serve patients across Colorado and the 7-state region. Increasing access to care for NSI's specialized services is a top priority to enable our families to live healthier lives. NSI Inpatient had 6,605 patient days recorded in 2020. There was a total of 1,299 inpatient discharges in 2020, and 756 neurosurgeries. In 2020, we opened a new Interventional Radiology suite, with new machines that produce CT scan-like cross-sectional images as well as 3D navigational images of blood vessels to enhance our ability to perform biopsies, drain complex collections, and treat vascular malformations. We saw a 6.1% decrease in 2020 in our Epilepsy Monitoring Unit admissions, for 2,640, due to COVID-19 pandemic, and challenges around COVID-19 testing. National/Regional Presence: NSI's outreach program extends from Montana to New Mexico with extensive presence in Colorado. We host over 100 Neurology outreach clinics annually across Colorado, in Alamosa, Durango, Ft. Morgan, Grand Junction, Montrose, Pueblo and Sterling. Our neurologists provide EEG reading services for 11 hospitals/medical centers in Colorado, Montana, Nebraska, and New Mexico. Our Developmental Pediatrics team travels throughout the state to train PCPs on best practices in diagnosing and managing patients with autism, with a focus on rural and frontier outreach clinics within the state and continues to expand the number of sites. We have a Developmental Pediatric psychologist work closely with the Pediatric Care Network (PCN) providers to educate them about how to obtain information needed to make a referral, provide them with easy to use templates, expedite assessments, and provide feedback about their initial impression of their patients after the assessment in Developmental Pediatrics, as a learning model for them. We continue to expand our regional partnerships, including ongoing exploration of outreach and telemedicine clinics in Casper, WY. NSI's Epilepsy program is accredited by the National Association of Epilepsy Centers as a Level 4 Epilepsy Center, which have the professional expertise and facilities to provide the highest level medical and surgical evaluation and treatment for patients with complex epilepsy. In 2020, our Epilepsy Monitoring Unit was accredited as an ABRET Long-Term Monitoring (LTM) laboratory, the only one in the Colorado and several surrounding states for either adult or pediatrics. We are recognized by the International Foundation for CDKL5 Research as Center of Excellence for Rett patients, one of only 15 institutions across the U.S., drawing patients nationally to be treated by Dr. Tim Benke, an international expert in this area. Our Neurology Complex Drugs Program draw patients from around the region to be treated for complex neurodegenerative diseases, and the program has been recognized as model for care for these treatments. Our faculty offer local and regional CMEs and organize an annual Rett Symposium and regular Seizure Safety Schools for parents and families. After several years of diligent advocacy by our physicians and genetic counselors, Colorado (and Wyoming) have included Spinal Muscular Atrophy in their Newborn Screening Programs. With 3 available treatments for this neurodegenerative disease, this screening, done in partnership with Children's Colorado, provides families with knowledge and options for their children. Quality Improvement: The NSI is committed to developing quality improvement as a core clinical strategy by continually advancing the effectiveness, efficiency, safety, experience and coordination of the care it provides to its patients. As a result of ongoing quality and process improvement initiatives, NSI has seen the following outcomes: . Seizure Free Rate (12 months post-surgery): 100% . SSI Bundle Compliance for Shunts: 90% . Shut Revisions within 90 days: 0% . Infantile Spasm LOS (% of pts with stay <4 days): 93% . EEG Lead Pressure Injuries (continuous EEG): 0.07% . Maintained high patient satisfaction scores: 89.1% across NSI, above Children's Ambulatory average of 88.9% NSI maintains a strong research portfolio, with faculty garnering numerous NIH and foundation grants in the past year. Within the hospital, we have the second largest portfolio of industry trials. With over 150 clinical research studies patients are ability to participate in new, emerging treatments for neurological disorders, including gene therapies. |
| FORM 990, PART VI, LINE 1A | CHILDREN'S HOSPITAL COLORADO'S EXECUTIVE COMMITTEE CONSISTS OF THE BOARD CHAIR, CHAIR ELECT, CHIEF EXECUTIVE OFFICER, SECRETARY, BOARD TREASURER, CORPORATE TREASURER, IMMEDIATE PAST CHAIR, THE CHAIR OF THE CHILDREN'S HOSPITAL COLORADO FOUNDATION, THE CHANCELLOR (OR DESIGNEE) AND UP TO TWO (2) ADDITIONAL SEATS TO BE FILLED BY THE BOARD CHAIR. THE EXECUTIVE COMMITTEE HAS ALL THE POWERS OF THE BOARD OF DIRECTORS, EXCEPT AS LIMITED BY LAW, DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS, SUBJECT TO ANY PRIOR LIMITATION IMPOSED BY THE BOARD. FORM 990, PART VI, LINE 6 CHILDREN'S HOSPITAL COLORADO HEALTH SYSTEM IS THE SOLE MEMBER OF CHILDREN'S HOSPITAL COLORADO. FORM 990, PART VI, LINE 7A THE WRITTEN CONSENT OF CHILDREN'S HOSPITAL COLORADO HEALTH SYSTEM IS REQUIRED TO APPROVE THE BOARD OF DIRECTORS OF CHILDREN'S HOSPITAL COLORADO. FORM 990, PART VI, LINE 7B CHILDREN'S HOSPITAL COLORADO HEALTH SYSTEM AS THE SOLE MEMBER HAS CERTAIN APPROVAL POWERS AS DESCRIBED IN THE AMENDED AND RESTATED BYLAWS DATED SEPTEMBER 22, 2011 AND AMENDED MOST RECENTLY IN FEBRUARY 2017. FORM 990, PART VI, Line 11B CHILDREN'S HOSPITAL COLORADO'S FINANCE DEPARTMENT WORKS CLOSELY WITH HUMAN RESOURCES, CORPORATE COMPLIANCE, LEGAL AND PUBLIC RELATIONS TO GATHER ALL THE DATA REQUIRED TO COMPLETE THE FORM 990. THE DIRECTOR OF ACCTG. & REPORTING CONDUCTS A REVIEW WITH THE CFO PRIOR TO THE DRAFT BEING DISTRIBUTED TO THE BOARD OF DIRECTORS. ANY NECESSARY CHANGES ARE MADE, THE FORM IS SIGNED BY THE CFO, REVIEWED BY THE AUDIT COMMITTEE, AND A FINAL COPY IS PROVIDED TO THE BOARD OF DIRECTORS PRIOR TO SUBMISSION TO THE IRS VIA A SECURED WEBSITE. FORM 990, PART VI, LINE 12C BOARD MEMBERS ARE REQUIRED TO DISCLOSE, ON AN ANNUAL BASIS, POTENTIAL CONFLICTS OF INTEREST PURSUANT TO THE WRITTEN POLICIES OF CHILDREN'S HOSPITAL COLORADO (CHCO) AND CHILDREN'S HOSPITAL COLORADO FOUNDATION (CHCF). ALL EMPLOYEES AND BOARD MEMBERS MUST PROMPTLY PROVIDE A WRITTEN DESCRIPTION OF MATERIAL FACTS OF AN ACTUAL, APPARENT OR POTENTIAL CONFLICT OF INTEREST TO CORPORATE COMPLIANCE AND/OR GENERAL COUNSEL ON THE APPROPRIATE DISCLOSURE FORM. SUCH DISCLOSURE WILL BE MADE PROMPTLY ANY TIME AN ACTUAL, APPARENT OR POTENTIAL CONFLICT OF INTEREST ARISES AND BEFORE THE CONSUMMATION OF THE CONTRACT, TRANSACTION OR ARRANGEMENT THAT IS THE SUBJECT OF THE POTENTIAL CONFLICT OF INTEREST. POLICIES AND PROCEDURES FOR DISCLOSING CONFLICTS OF INTEREST ARE TO BE FOLLOWED ACCORDING TO THE INDIVIDUAL'S FUNCTION, IN COMPLIANCE WITH STATE AND FEDERAL REGULATIONS. COMPLETED DISCLOSURE FORMS ARE SUBJECT TO AUDIT REVIEW BY LEGAL, THE CORPORATE COMPLIANCE PROGRAM, AND THE COMPLIANCE AND BUSINESS ETHICS COMMITTEE OF THE BOARD OF DIRECTORS. FAILURE TO COMPLY WITH CONFLICT OF INTEREST POLICIES MAY LEAD TO DISCIPLINARY ACTION UP TO AND INCLUDING TERMINATION OF EMPLOYMENT OR WORKING RELATIONSHIP WITH THE CHILDREN'S HOSPITAL COLORADO. ONCE THE COMPLIANCE AND BUSINESS ETHICS (CABE) COMMITTEE HAS DETERMINED THAT AN ACTUAL CONFLICT OF INTEREST EXISTS WITH RESPECT TO AN AGREEMENT/CONTRACT THEN: 1. THE (CABE) COMMITTEE WILL EXERCISE DUE DILIGENCE TO DETERMINE WHETHER CHILDREN'S HOSPITAL COULD OBTAIN A MORE ADVANTAGEOUS AGREEMENT/CONTRACT WITH REASONABLE EFFORTS UNDER THE CIRCUMSTANCES AND, IF APPROPRIATE, WILL APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED CONTRACT, TRANSACTION OR ARRANGEMENT. 2. IN CONSIDERING WHETHER TO ENTER THE PROPOSED AGREEMENT/CONTRACT, THE CABE COMMITTEE MAY APPROVE SUCH CONTRACT, TRANSACTION OR ARRANGEMENT ONLY IF THE DISINTERESTED PERSON OR COMMITTEE DETERMINE BY A MAJORITY VOTE THAT: - THE PROPOSED CONTRACT, TRANSACTION OR ARRANGEMENT IS IN CHILDREN'S COLORADO'S BEST INTERESTS AND FOR COLORADO CHILDREN'S OWN BENEFIT; AND - THE PROPOSED TRANSACTION IS FAIR AND REASONABLE TO CHILDREN'S HOSPITAL COLORADO (CHCO), CONSIDERING, AMONG OTHER RELEVANT FACTORS, WHETHER CHCO COULD OBTAIN A MORE ADVANTAGEOUS CONTRACT, TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS UNDER THE CIRCUMSTANCES. FORM 990, PART VI, LINES 15A AND 15B CHILDREN'S HOSPITAL COLORADO HAS AN EXECUTIVE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS THAT REVIEWS AND APPROVES ANY PROPOSED INCREASES RELATED TO ANY OFFICERS AND KEY EMPLOYEES OF THE COMPANY. THE CEO'S COMPENSATION IS REVIEWED AND APPROVED BY THE EXECUTIVE COMPENSATION COMMITTEE ALONG WITH THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS EACH YEAR. ONCE A CHANGE IN COMPENSATION IS APPROVED, FORMAL DOCUMENTS ARE COMPLETED AND MINUTES OF THE MEETING ARE PREPARED, REVIEWED AND APPROVED. EXECUTIVE COMPENSATION PROGRAMS FOR CHILDREN'S HOSPITAL COLORADO (CHCO) ARE DESIGNED TO ATTRACT AND RETAIN TOP EXECUTIVE TALENT. PROGRAM OBJECTIVES INCLUDE: -MAINTAIN EXECUTIVE PAY RANGES THAT REFLECT MARKET AND INTERNAL ALIGNMENT -ESTABLISH PAY FOR INDIVIDUAL EXECUTIVES BASED ON SKILLS, EXPERIENCE AND/OR PERFORMANCE HISTORY -PROVIDE ANNUAL PAY INCREASE TO REWARD INDIVIDUAL PERFORMANCE AND MAINTAIN MARKET COMPETITIVENESS -UTILIZE INCENTIVE PAY TO REWARD THE EXECUTIVE'S ABILITY TO ALIGN DIVISIONAL PERFORMANCE TO ORGANIZATIONAL PERFORMANCE -PROMOTE THE HEALTH AND WELLNESS OF EXECUTIVES AND THEIR FAMILIES, WHILE PROVIDING FAMILY FRIENDLY PROGRAM OPTIONS CONSISTENT WITH CHCO MISSION -MAINTAIN OVERALL PROGRAM AFFORDABILITY AND SUSTAINABILITY FOR THE ORGANIZATION THE EXECUTIVE COMPENSATION PACKAGE CONSISTS OF BASE PAY, INCENTIVE PAY, AND BENEFITS (MEDICAL, DENTAL, VISION, LIFE, DISABILITY, RETIREMENT, AND VOLUNTARY BENEFIT PROGRAMS). CHCO DEFINES MARKET COMPETITIVENESS BASED ON COMPARISONS WITH A PEER GROUP CONSISTING OF NATIONAL PEDIATRIC AND REGIONAL HEALTH SYSTEMS THAT ARE SIMILAR IN SIZE AND COMPLEXITY. IN DETERMINING MARKET COMPETITIVENESS, CHCO PARTNERS WITH AN EXTERNAL EXECUTIVE COMPENSATION CONSULTANT TO GATHER AND ASSESS MARKET DATA FROM INDEPENDENT COMPENSATION AND BENEFIT SURVEYS THAT REFLECT FUNCTIONALLY COMPARABLE POSITIONS IN THE PEER GROUP. AS NEEDED, THE EXTERNAL EXECUTIVE COMPENSATION CONSULTANT WILL PROVIDE RECOMMENDATIONS TO HELP RESOLVE DIFFICULTIES IN RECRUITING AND RETAINING EXECUTIVES OR ENSURE CRITICAL BUSINESS OR STRATEGIC ISSUES ARE ADDRESSED. 2020 CUSTOM PEER GROUP -TEXAS CHILDREN'S HOSPITAL (HOUSTON, TX) -THE CHILDREN'S HOSPITAL OF PHILADELPHIA (PHILADELPHIA, PA) -BOSTON CHILDREN'S HOSPITAL (BOSTON, MA) -CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI, OH) -NATIONWIDE CHILDREN'S HOSPITAL (COLUMBUS, OH) -CHILDREN'S HEALTHCARE OF ATLANTA (ATLANTA, GA) -COOK CHILDREN'S HEALTH CARE SYSTEM (FORT WORTH, TX) -CHILDREN'S HEALTH SYSTEM OF TEXAS (DALLAS, TX) -SEATTLE CHILDREN'S (SEATTLE, WA) -CHILDREN'S MERCY KANSAS CITY (KANSAS CITY, MO) -CHILDREN'S NATIONAL HEALTH SYSTEM (WASHINGTON, DC) -RADY CHILDREN'S HOSPITAL - SAN DIEGO (SAN DIEGO, CA) -CHILDREN'S HOSPITAL LOS ANGELES (LOS ANGELES, CA) -ANN & ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGO (CHICAGO, IL) -CHILDREN'S WISCONSIN (MILWAUKEE, WI) -CHILDREN'S HOSPITALS AND CLINICAL OF MINNESOTA (MINNEAPOLIS, MN) -PHOENIX CHILDREN'S HOSPITAL (PHOENIX, AZ) -CHOC CHILDREN'S (ORANGE, CA) -ARKANSAS CHILDREN'S HOSPITAL (LITTLE ROCK, AR) -UCHEALTH (AURORA, CO) -CENTURA HEALTH (CENTENNIAL, CO) -SCL HEALTH (BROOMFIELD, CO) -ST. LUKE'S HEALTH SYSTEM (BOISE, ID) THE COMPENSATION REVIEW PROCESS WAS LAST COMPLETED IN 2020. |
| FORM 990, PART VI, LINE 19 | THESE DOCUMENTS ARE MADE AVAILABLE UPON REASONABLE REQUEST. |
| FORM 990, PART XI, LINE 9 | EQUITY TRANSFER FROM CHCHS $ 7,680,610 EQUITY TRANSFER FROM FOUNDATION $39,946,614 CHANGE IN PERPETUAL TRUST $ 4,898,321 OTHER CHANGES IN NET ASSETS ($ 3,385,712) ------------- TOTAL $49,139,833 ============= |
| FORM 990 PART IX LINE 11G | DESCRIPTION:PHYSICIAN SERVICES TOTAL FEES:XXX-XX-XXXX |
| FORM 990 PART IX LINE 11G | DESCRIPTION:PURCHASED SERVICES TOTAL FEES:59156879 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:CONSULTING FEES TOTAL FEES:4865278 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:OTHER TOTAL FEES:6448603 |
| Software ID: | |
| Software Version: |